President Joe Biden (Susan Walsh/AP Images)
February 23, 2024 03:03 PM EST
Pharma
Law

Bi­par­ti­san group of law­mak­ers op­pos­es Biden's plan to use 'march-in' to low­er drug prices

Zachary Brennan

Senior Editor

A group of 28 sen­a­tors and mem­bers of Con­gress, in­clud­ing nine De­moc­rats, sent a let­ter to Pres­i­dent Joe Biden on Wednes­day de­cry­ing his ad­min­is­tra­tion’s re­cent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Chi­nese drug­mak­er re­ceives FDA warn­ing let­ter af­ter man­age­ment hin­dered in­spec­tion

GSK plots reg­u­la­to­ry fil­ings for PBC itch af­ter pos­i­tive Phase 3 read­out

Bio­gen, UCB de­tail re­sponse rates in Phase 3 lu­pus tri­al af­ter sur­pris­ing suc­cess

J&J, Pro­tag­o­nist re­veal two Phase 3 wins for oral IL-23 drug that's ex­pect­ed to be a block­buster

Law­mak­ers are pok­ing holes in phar­ma's fa­vorite new way to mar­ket med­i­cines

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times